ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.234,14
-1,15%
S&P 500
5.937,34
-0,21%
US Dollar vs BRL
6,0514
0,00%
Bitcoin
101.729,21
1,72%
Brent Oil
80,715
0,25%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) Notícias

GH

Guardant Health (GH)

Guardant Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH
DataHoraFonteTítuloCódigoCompanhia
16/01/202519:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
16/01/202510:05Business WireGuardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and DevelopmentNASDAQ:GHGuardant Health Inc
13/01/202518:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
13/01/202509:00Business WireGuardant Health Announces Preliminary Fourth Quarter and Full Year 2024 ResultsNASDAQ:GHGuardant Health Inc
07/01/202510:03Business WireGuardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer DetectionNASDAQ:GHGuardant Health Inc
02/01/202518:05Business WireGuardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GHGuardant Health Inc
20/12/202410:05Business WireMeaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer CareNASDAQ:GHGuardant Health Inc
19/12/202408:00Business WireCOTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI AnalyticsNASDAQ:GHGuardant Health Inc
18/12/202418:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
18/12/202410:05Business WireGuardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung CancerNASDAQ:GHGuardant Health Inc
09/12/202410:05Business WireGuardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer SymposiumNASDAQ:GHGuardant Health Inc
25/11/202419:09PR Newswire (US)Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™NASDAQ:GHGuardant Health Inc
13/11/202419:05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
06/11/202419:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
06/11/202418:05Business WireGuardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
01/11/202408:00Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
30/10/202410:30Business WireGuardant Health Named to TIME’s List of the Best Inventions of 2024NASDAQ:GHGuardant Health Inc
28/10/202409:05Business WireGuardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024NASDAQ:GHGuardant Health Inc
24/10/202418:05Business WireRoberto A. Mignone Joins Guardant Health Board of DirectorsNASDAQ:GHGuardant Health Inc
15/10/202417:05Business WireGuardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:GHGuardant Health Inc
18/09/202409:05Business WireGOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as LongNASDAQ:GHGuardant Health Inc
13/09/202413:08Business WireDans le cadre de l’ESMO 2024, Guardant Health présentera des données démontrant les solides performances de sa technologie d’oncologie de précision dans plusieurs types de tumeurs avancéesNASDAQ:GHGuardant Health Inc
13/09/202410:39Business WireGuardant Health wird auf der ESMO 2024 Daten vorstellen und damit die starke Leistung seiner Präzisionsonkologie-Technologie bei mehreren fortgeschrittenen Tumorarten weiter unter Beweis stellenNASDAQ:GHGuardant Health Inc
13/09/202403:00Business WireGuardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor TypesNASDAQ:GHGuardant Health Inc
10/09/202409:00Business WireGuardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in ItalyNASDAQ:GHGuardant Health Inc
27/08/202417:05Business WireGuardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:GHGuardant Health Inc
23/08/202417:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GHGuardant Health Inc
22/08/202418:00Business WireGuardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
07/08/202417:05Business WireGuardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/08/202409:05Business WireGuardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal CancerNASDAQ:GHGuardant Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GH

Seu Histórico Recente

EU
ARCPF
Arcona Property Fund NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados